Angelini Pharma, Lumira Ventures unveil biosciences fund

Angelini Pharma and Lumira Ventures have launched the Angelini Lumira Biosciences Fund with a $35 million commitment from Angelini.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this